<DOC>
	<DOCNO>NCT00262041</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity Novartis Meningococcal ACWY Conjugate Vaccine comparison license meningococcal polysaccharide vaccine administer healthy adolescent age 11 17 year .</brief_summary>
	<brief_title>Study Safety Immune Response Meningococcal Conjugate Vaccine Administered Healthy Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adolescent include 1117 year age , provide write informed consent Subjects previous suspect disease cause N. meningitidis ; previous immunization meningococcal vaccine vaccine contain meningococcal antigen ( ) ; Any serious acute , chronic progressive disease</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>